Translated Articles

《肿瘤学家》精选论文
Read translations of selected articles targeting practice issues relevant to Chinese clinicians.

Browse All Topics

The Oncologist in China

《肿瘤学家》中国项目概览
Download a 2-page pdf overview of The Oncologist’s Clinical Trial Results section information.

Video Library

视频库
Watch the latest presentations from the STO First Advisory Council: LUNG CANCER: A Grand Challenge for Public Health & Education.

Welcome to 'The Oncologist' in China

Recent Translated Articles from The Oncologist

Volume 22, Number 1, January 2017


Global Health and Cancer

中国实体瘤患者的临终化疗
Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies
Jin Sheng, Ya‐Xiong Zhang, Xiao‐Bo He, Wen‐Feng Fang, Yun‐Peng Yang, Gui‐Nan Lin, Xuan Wu, Ning Li, Jing Zhang, Lin‐Zhu Zhai, Yuan‐Yuan Zhao, Yan Huang, Ning‐Ning Zhou, Hong‐Yun Zhao, Li Zhang
The Oncologist 2017; 22:53-60; first published on October 27, 2016; doi:10.1634/theoncologist.2016-0013

对全身治疗反应不一显示出非小细胞肺癌患者可能存在遗传异质性且生存期不佳
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non‐Small Cell Lung Cancer
Zhong‐Yi Dong, Hao‐Ran Zhai, Qing‐Yi Hou, Jian Su, Si‐Yang Liu, Hong‐Hong Yan, Yang‐Si Li, Zhi‐Yong Chen, Wen‐Zhao Zhong, Yi‐Long Wu
The Oncologist 2017; 22:61-69; doi:10.1634/theoncologist.2016-0150

Volume 21, Number 12, December 2016


Clinical Trial Results

醋酸阿比特龙联合泼尼松治疗转移性前列腺癌黑人男性患者的II期临床试验
Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer
Che-Kai Tsao, John Sfakianos, Bobby Liaw, Kiev Gimpel-Tetra, Margaret Kemeny, Linda Bulone, Mohammad Shahin, William Kyu Oh, Matthew David Galsky
The Oncologist 2016; 21:1414-e9; first published on October 14, 2016; doi:10.1634/theoncologist.2016-0026

卡巴他赛与甲氨蝶呤用于曾接受含铂方案治疗的复发性和/或转移性头颈鳞癌患者:随机II期研究
Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy
Jean-Pascal Machiels, Aline Van Maanen, Jean-Marie Vandenbulcke, Bertrand Filleul, Emmanuel Seront, Stéphanie Henry, Lionel D’Hondt, Christophe Lonchay, Stéphane Holbrechts, Petra Boegner, Dany Brohee, Didier Dequanter, Ingrid Louviaux, Brieuc Sautois, Nicolas Whenham, Guy Berchem, Brigitte Vanderschueren, Christel Fontaine, Sandra Schmitz, Aline Gillain, Joelle Schoonjans, Sylvie Rottey
The Oncologist 2016; 21:1416-e17; first published on November 30, 2016; doi:10.1634/theoncologist.2016-0296

Head and Neck Cancers

针刺治疗用于头颈癌患者的化放疗相关性吞咽困难:初步假对照临床试验
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial
Weidong Lu, Peter M. Wayne, Roger B. Davis, Julie E. Buring, Hailun Li, Eric A. Macklin, Jochen H. Lorch, Elaine Burke, Tyler C. Haddad, Laura A. Goguen, David S. Rosenthal, Roy B. Tishler, Marshall R. Posner, Robert I. Haddad
The Oncologist 2016; 21:1522-1529; first published on August 10, 2016; doi:10.1634/theoncologist.2015-0538

Hepatobiliary

起始不可手术肝细胞癌患者在行经动脉化疗栓塞治疗降期后是否有必要进行挽救性肝切除?10年经验
Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience
Yingqiang Zhang, Guihua Huang, Yu Wang, Lijian Liang, Baogang Peng, Wenzhe Fan, Jianyong Yang, Yonghui Huang, Wang Yao, Jiaping Li
The Oncologist 2016; 21:1442-1449; first published on August 2, 2016; doi:10.1634/theoncologist.2016-0094

Lung Cancer

非小细胞肺癌中的KRAS通路靶点
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Pascale Tomasini, Preet Walia, Catherine Labbe, Kevin Jao, Natasha B. Leighl
The Oncologist 2016; 21:1450-1460; first published on November 2, 2016; doi:10.1634/theoncologist.2015-0084

No front page content has been created yet.

 

The Oncologist and the Society for Translational Oncology (STO) partner with the Chinese Society of Clinical Oncology (中国抗癌协会临床肿瘤学协作专业委员会, CSCO) and the CSCO Foundation (中国临床肿瘤学会基金会) on educational initiatives that address critical health and cancer care issues in China. These efforts serve to foster communication between Chinese physicians and other leaders in oncology practice throughout the world.